Replies to post #449300 on Anavex Life Sciences Corp (AVXL)

[boi568]

You are factually wrong to assert that a 1:1 ratio in the 92 patient EXCELLENCE trial would have resulted in a trial n as large as the 187 patient LAVENDER trial.

[bas2020]

My point... I'm glad you concur that blarcamesine is a very efficacious therapy for Rett patients.
If you see it, then surely the RAs will, as well.